Similar articles for PMID: 23666891

Year	Number of Results
1994	1
1995	2
1997	1
1998	2
1999	4
2000	2
2002	3
2003	1
2004	2
2005	4
2006	2
2007	3
2008	2
2009	4
2010	2
2011	4
2012	6
2013	5
2014	1
2015	2
2016	1
2018	2
2019	4
2020	3
2021	1
2024	0

1

Pegylated IL-10 induces cancer immunity: the surprising role of IL-10 as a potent inducer of IFN-γ-mediated CD8(+) T cell cytotoxicity.

Mumm JB, Oft M. Mumm JB, et al. Bioessays. 2013 Jul;35(7):623-31. doi: 10.1002/bies.201300004. Epub 2013 May 13. Bioessays. 2013. PMID: 23666891 Review.

2

IL-10: master switch from tumor-promoting inflammation to antitumor immunity.

Oft M. Oft M. Cancer Immunol Res. 2014 Mar;2(3):194-9. doi: 10.1158/2326-6066.CIR-13-0214. Cancer Immunol Res. 2014. PMID: 24778315

3

IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.

Apte SH, Groves P, Olver S, Baz A, Doolan DL, Kelso A, Kienzle N. Apte SH, et al. J Immunol. 2010 Jul 15;185(2):998-1004. doi: 10.4049/jimmunol.0903372. Epub 2010 Jun 18. J Immunol. 2010. PMID: 20562261

4

IL-10 directly activates and expands tumor-resident CD8(+) T cells without de novo infiltration from secondary lymphoid organs.

Emmerich J, Mumm JB, Chan IH, LaFace D, Truong H, McClanahan T, Gorman DM, Oft M. Emmerich J, et al. Cancer Res. 2012 Jul 15;72(14):3570-81. doi: 10.1158/0008-5472.CAN-12-0721. Epub 2012 May 11. Cancer Res. 2012. PMID: 22581824

5

PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8⁺ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients.

Naing A, Infante JR, Papadopoulos KP, Chan IH, Shen C, Ratti NP, Rojo B, Autio KA, Wong DJ, Patel MR, Ott PA, Falchook GS, Pant S, Hung A, Pekarek KL, Wu V, Adamow M, McCauley S, Mumm JB, Wong P, Van Vlasselaer P, Leveque J, Tannir NM, Oft M. Naing A, et al. Cancer Cell. 2018 Nov 12;34(5):775-791.e3. doi: 10.1016/j.ccell.2018.10.007. Cancer Cell. 2018. PMID: 30423297 Free PMC article.

6

Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.

Balkow S, Loser K, Krummen M, Higuchi T, Rothoeft T, Apelt J, Tuettenberg A, Weishaupt C, Beissert S, Grabbe S. Balkow S, et al. Exp Dermatol. 2009 Jan;18(1):78-87. doi: 10.1111/j.1600-0625.2008.00800.x. Epub 2008 Oct 22. Exp Dermatol. 2009. PMID: 19054060

7

Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.

Komita H, Homma S, Saotome H, Zeniya M, Ohno T, Toda G. Komita H, et al. J Hepatol. 2006 Nov;45(5):662-72. doi: 10.1016/j.jhep.2006.05.018. Epub 2006 Jul 7. J Hepatol. 2006. PMID: 16935390

8

Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.

Eguchi J, Hiroishi K, Ishii S, Mitamura K. Eguchi J, et al. Cancer Immunol Immunother. 2003 Jun;52(6):378-86. doi: 10.1007/s00262-002-0367-2. Epub 2003 Mar 18. Cancer Immunol Immunother. 2003. PMID: 12739068

9

IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.

Tajima M, Wakita D, Satoh T, Kitamura H, Nishimura T. Tajima M, et al. Int Immunol. 2011 Dec;23(12):751-9. doi: 10.1093/intimm/dxr086. Epub 2011 Oct 29. Int Immunol. 2011. PMID: 22039016

10

Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.

Ye Z, Tang C, Xu S, Zhang B, Zhang X, Moyana T, Yang J, Xiang J. Ye Z, et al. Cell Mol Immunol. 2007 Aug;4(4):277-85. Cell Mol Immunol. 2007. PMID: 17764618 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

62 results

Results by year